Transcatheter Technologies GmbH, a medical device company, announced the successful first-in-human implantation of its transapical Trinity aortic valve.
Medical experts released “Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists.”
If you enjoy this content, please share it with a colleague
AirStrip announced new research demonstrating the results of its mobility solution AirStrip One Cardiology, along with successful use cases by Rockdale Medical Center, Palomar Health, Montefiore Medical Center and Sequoia Hospital.
PDI, Inc. and Transgenomic, Inc. announced the signing of a U.S. collaboration agreement to commercialize CardioPredict, a molecular diagnostic test developed by Transgenomic. CardioPredict is a broad-based genetic assay which identifies specific genes in patients that influence the effectiveness and safety of many commonly used cardiovascular drugs.
UC Davis Health System researchers have identified for the first time a biological pathway that is activated when blood sugar levels are abnormally high and causes irregular heartbeats, a condition known as cardiac arrhythmia that is linked with heart failure and sudden cardiac death.
Sunshine Heart Inc. announced its collaboration with Minnetronix for a transcutaneous energy transfer (TET) system to power the company's fully-implantable C-Pulse Heart Assist System under development. The agreement leverages Minnetronix's existing TET technology and includes milestone payments due to Minnetronix prior to U.S. regulatory approval for the fully-implantable C-Pulse system.
In a paper e-published in Catheterization and Cardiovascular Interventions, the Society for Cardiovascular Angiography and Interventions (SCAI) examined the current state of medical simulation in interventional cardiology and issued recommendations for expanding and standardizing the use of the lifelike training technology by practicing interventional cardiologists and fellows-in-training
